LIke ThisLIke ThisLIke This

Christopher John  Recklitis, PhD, MPH

C J Recklitis, PhD, MPH
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Medicine Research
Hematology/Oncology Research
Hospital Title:
Principal Investigator
Academic Title:
Assistant Professor of Pediatrics, Harvard Medical School
Research Focus Area:
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Dr. Recklitis' research interests are in the areas of health psychology and mental health outcomes of oncology patients. His research is focused on understanding the psychological late-effects of cancer, the development of effective screening measures for detecting distress, and the best methods for encouraging health protective behaviors in cancer survivors. Dr. Recklitis' projects include an evaluation of a mental health screening program for a long-term survivor clinic, a study of depression and suicidality in adult survivors of childhood cancer, an investigation of response bias in self-reported quality-of-life in Hodgkin's disease survivors, and an intervention study using Ultraviolet Light Photography to increase sun protection behaviors in cancer survivors. He is the Principal Investigator of Project REACH, a longitudinal study of health outcomes in more than00 locally treated cancer survivors. His work has been supported by grants from the National Cancer Institute, Lance Armstrong Foundation, American Foundation for the Prevention of Suicide, and the Childhood Brain Tumor Foundation.

About Christopher Recklitis

Dr. Recklitis completed his PhD in clinical psychology at Boston University, and his Masters degree in Public Health at the Harvard School of Public Health.

LIke ThisLIke ThisLIke This


Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more